Effects of cinobufacini injection on cell proliferation and the expression of topoisomerases in human HepG-2 hepatocellular carcinoma cells

被引:25
作者
Liu, Ying [1 ]
Ban, Li-Ying [1 ]
Su, Xi [1 ]
Gao, Shan [1 ]
Liu, Ji-Wei [1 ]
Cui, Xiao-Nan [1 ]
机构
[1] Dalian Med Univ, Affiliated Hosp 1, Dept Oncol, Dalian 116011, Liaoning, Peoples R China
基金
中国国家自然科学基金;
关键词
cinobufacini injection; HepG-2; cells; proliferation; apoptosis; topoisomerase I; topoisomerase II; PROSTATE-CANCER CELLS; DNA; BUFALIN; APOPTOSIS; HUACHANSU; PATHWAYS; THERAPY; DEATH; PHASE;
D O I
10.3892/mmr.2015.3552
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The present study aimed to investigate the effects of cinobufacini injection on the proliferation and expression of topoisomerases in human HepG-2 hepatocarcinoma cells. The cells were divided into a control group and an experimental group, in which 0.105, 0.21, 0.42 mg/l cinobufacini was injected. Cell proliferation was assessed using a 3-(4,5-dimethylthiazol-2-yl) -2,5-diphenyltetrazolium bromide assay, levels of apoptosis were detected using annexin V/propidium iodide staining and cell cycles were analyzed using flow cytometric analysis. The mRNA and protein expression levels of topoisomerase (TOPO) I and TOPO II were determined by reverse transcription-quantitative polymerase chain reaction and western blotting, respectively. Cinobufacini injection significantly inhibited the proliferation of the HepG-2 cells (P<0.05), induced apoptosis (P<0.05) in a dose- and time-dependent manner, induced tumor cell arrest at the S phase in a dose-dependent manner, and downregulated the mRNA and protein expression levels of TOPO I and TOPO II (P<0.05) in a dose-dependent manner. Therefore, cinobufacini was found to inhibit human HepG-2 hepatocellular carcinoma cell proliferation, and downregulation of the expression levels of TOPO I and TOPO II may contribute to the effect on proliferation observed in the Hep-G(2) cells following cinobbufacini injection.
引用
收藏
页码:1598 / 1604
页数:7
相关论文
共 32 条
[11]   Cytometric assessment of DNA damage in relation to cell cycle phase and apoptosis [J].
Huang, X ;
Halicka, HD ;
Traganos, F ;
Tanaka, T ;
Kurose, A ;
Darzynkiewicz, Z .
CELL PROLIFERATION, 2005, 38 (04) :223-243
[12]  
Liu Huaimin, 2011, CHINESE J EXPT TRADI, V17, P235, DOI [10.13422/j.cnki.syfjx.2011.05.084, DOI 10.13422/J.CNKI.SYFJX.2011.05.084]
[13]   TCH-1030 targeting on topoisomerase I induces S-phase arrest, DNA fragmentation, and cell death of breast cancer cells [J].
Liu, Yu-Peng ;
Chen, Hui-Ling ;
Tzeng, Cherng-Chyi ;
Lu, Pei-Jung ;
Lo, Cheng-Wei ;
Lee, Yu-Cheng ;
Tseng, Chih-Hua ;
Chen, Yeh-Long ;
Yang, Chia-Ning .
BREAST CANCER RESEARCH AND TREATMENT, 2013, 138 (02) :383-393
[14]   Pilot Study of Huachansu in Patients With Hepatocellular Carcinoma, Nonsmall-Cell Lung Cancer, or Pancreatic Cancer [J].
Meng, Zhiqiang ;
Yang, Peiying ;
Shen, Yehua ;
Bei, Wenying ;
Zhang, Ying ;
Ge, Yongqian ;
Newman, Robert A. ;
Cohen, Lorenzo ;
Liu, Luming ;
Thornton, Bob ;
Chang, David Z. ;
Liao, Zongxing ;
Kurzrock, Razelle .
CANCER, 2009, 115 (22) :5309-5318
[15]  
Nitiss JL, 1996, MOL PHARMACOL, V50, P1095
[16]  
Pan YQ, 2011, MED IMFORMATION, V2, P415
[17]  
POTMESIL M, 1988, CANCER RES, V48, P3537
[18]   Bufalin and cinobufagin induce apoptosis of human hepatocellular carcinoma cells via Fas- and mitochondria-mediated pathways [J].
Qi, Fanghua ;
Inagaki, Yoshinori ;
Gao, Bo ;
Cui, Xiaoyan ;
Xu, Huanli ;
Kokudo, Norihiro ;
Li, Anyuan ;
Tang, Wei .
CANCER SCIENCE, 2011, 102 (05) :951-958
[19]  
Qi FH, 2010, BIOSCI TRENDS, V4, P297
[20]   Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor [J].
Qi, Fanghua ;
Li, Anyuan ;
Inagaki, Yoshinori ;
Kokudo, Norihiro ;
Tamura, Sumihito ;
Nakata, Munehiro ;
Tang, Wei .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2011, 11 (03) :342-349